Anthem to Cover Quanterix’s LucentAD Complete Alzheimer’s Blood Test
The insurer will provide coverage for the multi-analyte test starting July 2026, following new data showing parity with mass spectrometry.
Read More
Search Results for: liver disease
Labcorp Expands Access to Non-Invasive MASH Blood Test Through Online Platform
The NASHnext assay, powered by GENFIT’s NIS4 technology, is designed to identify patients with at-risk MASH through a blood draw ordered via the Labcorp OnDemand platform.
Read More
Roche Introduces Automated Test for Hepatitis D Virus
The fully automated, high-throughput assay for Hepatitis D virus RNA is available on cobas 5800/6800/8800 systems in CE mark-accepting countries.
Read More
Beckman Coulter Receives CE Mark for Automated p-Tau217 Alzheimer’s Blood Test
The p-Tau217 assay runs on the DxI 9000 Immunoassay Analyzer, enabling laboratories to incorporate blood-based Alzheimer’s biomarker testing into high-throughput workflows.
Read More
FDA-Approved PTEN Companion Diagnostic Becomes Available for Prostate Cancer Patients
NeoGenomics has launched the first FDA-approved PTEN IHC companion diagnostic for prostate adenocarcinoma, enabling identification of patients with PTEN deficiency who may benefit from AstraZeneca’s capivasertib therapy.
Read More